Bristol-Myers Squibb Company (BMY)
Healthcare
Drug Manufacturers - General
65.50 $
+0.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns Bristol-Myers Squibb Company (BMY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.8% of the shares are freely tradable; institutional investors hold 83.8%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
83.8%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
2.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
2,043Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.40 | 171,682,888 | -2.9 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.48 | 132,320,240 | +0.0 | 03/31/2026 |
| State Street Corp | 4.83 | 98,564,914 | +0.6 | 03/31/2026 |
| JPMorgan Chase & Co | 4.53 | 92,475,194 | +22.7 | 03/31/2026 |
| Charles Schwab Investment Management Inc | 2.99 | 61,115,373 | -14.3 | 03/31/2026 |
| Geode Capital Management, LLC | 2.71 | 55,286,174 | +5.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.26 | 46,230,155 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 3.17 | 64,840,247 | +0.0 | 06/30/2026 |
| Schwab US Dividend Equity ETF™ | 2.62 | 53,565,446 | +0.2 | 07/30/2026 |
| Vanguard 500 Index Investor | 2.60 | 53,047,466 | -0.5 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.